4
Changes in Ownership
Twist Bioscience Corp Filed Acc 0001214659-26-010645
President and COO sold 78,355 shares at an average $117.64 ($9,217,607)
- President and COO acquired 23,355 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Finn Patrick John · President and COO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-18 | Exercise or conversion : show line 1 in the form 10b5-1 | +23,355 | $67.85 | $1,584,637 | 293,033 | D |
| 2026-08-18 | Sale : show line 2 in the form 10b5-1 | −33,354 | $115.90 | $3,865,695 | 259,679 | D |
| 2026-08-18 | Sale : show line 3 in the form 10b5-1 | −10,420 | $116.82 | $1,217,266 | 249,259 | D |
| 2026-08-18 | Sale : show line 4 in the form 10b5-1 | −8,868 | $117.70 | $1,043,737 | 240,391 | D |
| 2026-08-18 | Sale : show line 5 in the form 10b5-1 | −4,500 | $119.04 | $535,680 | 235,891 | D |
| 2026-08-18 | Sale : show line 6 in the form 10b5-1 | −12,917 | $119.86 | $1,548,206 | 222,974 | D |
| 2026-08-18 | Sale : show line 7 in the form 10b5-1 | −6,296 | $121.01 | $761,860 | 216,678 | D |
| 2026-08-18 | Sale : show line 8 in the form 10b5-1 | −2,000 | $122.58 | $245,162 | 214,678 | D |
| Open-market sales · 78,355 sh · avg $117.64 · $9,217,607 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-18 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) | −23,355 | 0 | D |
Loading xslF345X06/marketforms-73808.xml…